|
|
Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 76 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData’s new report, “Neurostimulation Devices – Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016” provides key data, information and analysis on the glo.....
Introduction GlobalData’s new report, “Neurostimulation Devices – Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016” provides key data, information and analysis on the global neurostimulation devices market. The report provides market landscape, competitive landscape and market trends information the neurostimulation devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil. - Key segments covered include Deep Brain Stimulators, Spinal Cord Stimulators and Vagus Nerve Stimulators. - Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009. - Qualitative analysis of key market trends, market drivers, and restraints by each category within the neurostimulation devices market. - The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies. - Key players covered include Medtronic, St. Jude Medical, Boston Scientific Corporation and Cyberonics. Highlights Reasons to buy - Develop business strategies by understanding the trends and developments that are driving the neurostimulation devices market globally. - Design and develop your product development, marketing and sales strategies. - Exploit M&A opportunities by identifying market players with the most innovative pipeline. - Develop market-entry and market expansion strategies. - Identify key players best positioned to take advantage of the emerging market opportunities. - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return. - What’s the next being thing in the neurostimulation devices market landscape? – Identify, understand and capitalize. - Make more informed business decisions from the insightful and in-depth analysis of the global neurostimulation devices market and the factors shaping it. Report Highlights Medtronic, Inc St. Jude Medical, Inc Boston Scientific Corporation Cyberonics, Inc [Studien Infos ausblenden] |
|||||||||||
|
TABLE OF CONTENTS 1 Table of contents 1 Table of contents 3 1.1 List of Tables 6 1.2 List of Figures 7 2 Introduction and Overview 8 2.1 GlobalData Report Guidance 8 3 Disease Overview 9 3.1 Disease Overview: Parkinson’s Disease 9 3.1.1 Introduction 9 3.1.2 Etiology 9 3.1.3 Signs and Symptoms 10 3.1.4 Pathophysiology 10 3.1.5 Treatment 11 3.1.6 Epidemiology 11 3.2 Disease Overview: Chronic Pain 11 3.2.1 Introduction 11 3.2.2 Etiology 12 3.2.3 Signs and Symptoms 12 3.2.4 Pathophysiology 12 3.2.5 Treatment 12 3.2.6 Epidemiology 13 3.3 Disease Overview: Epilepsy 13 3.3.1 Introduction 13 3.3.2 Etiology 14 3.3.3 Signs and Symptoms 14 3.3.4 Pathophysiology 14 3.3.5 Treatment 15 3.3.6 Epidemiology 15 4 Neurostimulation Device Based Treatment Overview 16 4.1 Neurostimulation Devices: Technology Overview 16 4.1.1 Introduction 16 4.1.2 Advantages and Disadvantages of Neurostimulation Therapy 17 4.1.3 Types of Neurostimulators 17 5 Global Neurostimulation Devices Market: Global Market Characterization 19 5.1 Global Neurostimulation Devices Market, Revenues($m), 2002 ? 2009 19 5.2 Global Neurostimulation Devices Market, Revenues($m), 2009 ? 2016 20 5.3 Neurostimulation Devices: Key Market Trends 21 5.4 Neurostimulation Devices: Market Dynamics 21 5.4.1 Market Drivers 21 5.4.2 Market Restraints 23 5.5 Neurostimulation Devices: Key Opportunities and Unmet Needs 23 5.5.1 Opportunities 23 5.5.2 Unmet Need 24 6 Global Neurostimulation Devices Market: Segment Wise Analysis 25 6.1 Deep Brain Stimulation Devices Market: Market Characterization 25 6.1.1 Deep Brain Stimulation Devices Market, Revenues ($m), 2002 ? 2009 25 6.1.2 Deep Brain Stimulation Devices Market, Revenues ($m), 2009 ? 2016 26 6.2 Spinal Cord Stimulation Devices Market: Market Characterization 27 6.2.1 Spinal Cord Stimulation Devices Market, Revenues ($m), 2002 ? 2009 27 6.2.2 Spinal Cord Stimulation Devices Market, Revenues ($m), 2009 ? 2016 28 6.3 Vagus Nerve Stimulation Devices Market: Market Characterization 29 6.3.1 Vagus Nerve Stimulation Devices Market, Revenues ($m), 2002 ? 2009 29 6.3.2 Vagus Nerve Stimulation Devices Market, Revenues ($m), 2009 ? 2016 30 7 Global Neurostimulation Devices Market: Country Wise Market Analysis and Forecasts 31 7.1 Global Neurostimulation Devices Market: Cross-Country Market Analysis and Forecasts 31 7.1.1 Cross-Country Analysis of Neurostimulation Devices market, 2009 31 7.2 Revenues and Forecasts, By Country 32 7.2.1 US Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 32 7.2.2 US Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 33 7.2.3 Canada Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 34 7.2.4 Canada Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 35 7.2.5 UK Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 36 7.2.6 UK Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 37 7.2.7 Germany Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 38 7.2.8 Germany Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 39 7.2.9 France Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 40 7.2.10 France Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 41 7.2.11 Italy Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 42 7.2.12 Italy Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 43 7.2.13 Spain Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 44 7.2.14 Spain Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 45 7.2.15 Japan Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 46 7.2.16 Japan Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 47 7.2.17 China Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 48 7.2.18 China Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 49 7.2.19 India Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 50 7.2.20 India Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 51 7.2.21 Australia Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 ? 2009 52 7.2.22 Australia Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 53 7.2.23 Brazil Neurostimulation Devices Market, Revenues ($m), By Segment, 2002 – 2009 54 7.2.24 Brazil Neurostimulation Devices Market, Revenues ($m), By Segment, 2009 – 2016 55 8 Global Neurostimulation Devices Market: Competitive Assessment 56 8.1 Global Neurostimulation Devices Market, Key Company Shares (%), 2009 56 8.2 Medtronic, Inc 57 8.2.1 Overview 57 8.2.2 Neurostimulation Devices Portfolio 57 8.3 St. Jude Medical, Inc 57 8.3.1 Overview 57 8.3.2 Neurostimulation Devices Portfolio 57 8.4 Boston Scientific Corporation 58 8.4.1 Overview 58 8.4.2 Neurostimulation Devices Portfolio 58 8.5 Cyberonics, Inc 58 8.5.1 Overview 58 8.5.2 Neurostimulation Devices Portfolio 58 9 Global Neurostimulation Devices Market: Key Marketed Products 59 9.1 Medtronic, Inc: Activa RC 59 9.1.1 Product Description 59 9.1.2 Features and Benefits 59 9.2 Medtronic, Inc: RestoreUltra 59 9.2.1 Product Description 59 9.2.2 Features and Benefits 59 9.3 St. Jude’s Medical, Inc: Eon Mini 59 9.3.1 Product Description 59 9.3.2 Features and Benefits 59 9.4 Boston Scientific Corporation: Precision Plus 60 9.4.1 Product Description 60 9.4.2 Features and Benefits 60 9.5 Cyberonics, Inc: VNS Therapy 60 9.5.1 Product Description 60 9.5.2 Features and Benefits 60 10 Global Neurostimulation Devices Market: Strategic Pipeline Assessment 61 10.1 Neurostimulation Devices: List of Pipeline Products 61 10.2 Pipeline Products Assessment for Neurostimulation Devices by Segment, Global, 2010 64 10.3 Neurostimulation Devices: Profiles of Pipeline Products Under Clinical Development 65 10.3.1 Cyberonics, Inc: 3T MRI Safe Lead 65 10.3.2 Boston Scientific Corporation: Bion Microstimulator System for chronic headache 65 10.3.3 Brainsway, Inc: Deep TMS H System 65 10.3.4 Intelect Medical, Inc: Enspire DBS Therapy System for Stroke 65 10.3.5 Magstim Company Limited: Magstim eldith DC Stimulator plus 65 10.3.6 DynaMed Systems, LLC: Traxon 66 11 Global Neurostimulation Devices Market: M&A Landscape 67 11.1 Global Neurostimulation Devices Market: Deals Overview 67 11.2 Global Neurostimulation Devices Market: Key Acquisitions 68 11.2.1 St. Jude Medical Acquires Northstar Neuroscience 69 11.2.2 Greatbatch Acquires Quan Emerteq 69 11.2.3 Greatbatch Acquires Enpath Medical 70 12 Appendix 71 12.1 Definitions 71 12.2 Acronyms 71 12.3 Information Sources 73 12.4 Research Methodology 73 12.5 Secondary Research 74 12.6 Primary Research 75 12.7 Models 75 12.8 Forecasts 75 12.9 Expert Panels 75 12.10 GlobalData Consulting 76 12.11 Contact Us 76 12.12 Disclaimer 76 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
LIST OF TABLES 1.1 List of Tables Table 1: Neurostimulation Devices Market, Global, Revenues ($m), 2002 ? 2009 19 Table 2: Neurostimulation Devices Market, Global, Revenues ($m), 2009 ? 2016 20 Table 3: Deep Brain Stimulation Devices Market, Global, Revenues ($m), 2002 ? 2009 25 Table 4: Deep Brain Stimulation Devices Market, Global, Revenues ($m), 2009 ? 2016 26 Table 5: Spinal Cord Stimulation Devices Market, Global, Revenues ($m), 2002 ? 2009 27 Table 6: Spinal Cord Stimulation Devices Market, Global, Revenues ($m), 2009 ? 2016 28 Table 7: Vagus Nerve Stimulation Devices Market, Global, Revenues ($m), 2002 ? 2009 29 Table 8: Vagus Nerve Stimulation Devices Market, Global, Revenues ($m), 2009 ? 2016 30 Table 9: Neurostimulation Devices Market, Global, Market Analysis by Countries, 2002 ? 2016 31 Table 10: Neurostimulation Devices Market, US, Revenues ($m), By Segment, 2002 – 2009 32 Table 11: Neurostimulation Devices Market, US, Revenues ($m), By Segment, 2009 – 2016 33 Table 12: Neurostimulation Devices Market, Canada, Revenues ($m), By Segment, 2002 – 2009 34 Table 13: Neurostimulation Devices Market, Canada, Revenues ($m), By Segment, 2009 – 2016 35 Table 14: Neurostimulation Devices Market, UK, Revenues ($m), By Segment, 2002 – 2009 36 Table 15: Neurostimulation Devices Market, UK, Revenues ($m), By Segment, 2009 – 2016 37 Table 16: Neurostimulation Devices Market, Germany, Revenues ($m), By Segment, 2002 – 2009 38 Table 17: Neurostimulation Devices Market, Germany, Revenues ($m), By Segment, 2009 – 2016 39 Table 18: Neurostimulation Devices Market, France, Revenues ($m), By Segment, 2002 – 2009 40 Table 19: Neurostimulation Devices Market, France, Revenues ($m), By Segment, 2009 – 2016 41 Table 20: Neurostimulation Devices Market, Italy, Revenues ($m), By Segment, 2002 – 2009 42 Table 21: Neurostimulation Devices Market, Italy, Revenues ($m), By Segment, 2009 – 2016 43 Table 22: Neurostimulation Devices Market, Spain, Revenues ($m), By Segment, 2002 – 2009 44 Table 23: Neurostimulation Devices Market, Spain, Revenues ($m), By Segment, 2009 – 2016 45 Table 24: Neurostimulation Devices Market, Japan, Revenues ($m), By Segment, 2002 – 2009 46 Table 25: Neurostimulation Devices Market, Japan, Revenues ($m), By Segment, 2009 – 2016 47 Table 26: Neurostimulation Devices Market, China, Revenues ($m), By Segment, 2002 – 2009 48 Table 27: Neurostimulation Devices Market, China, Revenues ($m), By Segment, 2009 – 2016 49 Table 28: Neurostimulation Devices Market, India, Revenues ($m), By Segment, 2002 – 2009 50 Table 29: Neurostimulation Devices Market, India, Revenues ($m), By Segment, 2009 – 2016 51 Table 30: Neurostimulation Devices Market, Australia, Revenues ($m), By Segment, 2002 ? 2009 52 Table 31: Neurostimulation Devices Market, Australia, Revenues ($m), By Segment, 2009 – 2016 53 Table 32: Neurostimulation Devices Market, Brazil, Revenues ($m), By Segment, 2002 – 2009 54 Table 33: Neurostimulation Devices Market, Brazil, Revenues ($m), By Segment, 2009 – 2016 55 Table 34: Neurostimulation Devices Market, Global, Key Company Shares ($m), 2009 56 Table 35: Medtronic, Inc., Key Marketed Products, Neurostimulation Devices Category 57 Table 36: St. Jude Medical, Inc. Key Marketed Products, Neurostimulation Devices Category 57 Table 37: Boston Scientific Corp., Key Marketed Products, Neurostimulation Devices Category 58 Table 38: Cyberonics, Inc , Key Marketed Products, Neurostimulation Devices Category 58 Table 39: Activa RC Deep Brain Neurostimulator, Features and Benefits 59 Table 40: RestoreUltra Spinal Cord Neurostimulator, Features and Benefits 59 Table 41: Eon Mini Spinal Cord Stimulator, Features and Benefits 59 Table 42: Precision Plus Spinal Cord Stimulator, Features and Benefits 60 Table 43: VNS Therapy Features and Benefits 60 Table 44: Neurostimulation Devices, Pipeline Products, 2010, Table 1 61 Table 45: Neurostimulation Devices, Pipeline Products, 2010, Table 2 62 Table 46: Neurostimulation Devices, Pipeline Products, 2010, Table 3 63 Table 47: Neurostimulation Devices Market, Global, Deals Overview, 2005 ? 2009 67 Table 48: Neurostimulation Devices Market, Global, M&A Deal Value ($m), 2005 ? 2009 68 Table 49: Neurostimulation Devices Industry, Global, List of M&A Deals, 2004 ? 2010 69 LIST OF FIGURES 1.2 List of Figures Figure 1: Neurostimulation Therapy, FDA Year of Approval 17 Figure 2: Neurostimulation Devices Market, Global, Revenues ($m), 2002 ? 2009 19 Figure 3: Neurostimulation Devices Market, Global, Revenues ($m), 2009 ? 2016 20 Figure 4: Potential of Neurostimulation Devices for the Treatment of Various Indications, 2010 21 Figure 5: Deep Brain Stimulation Devices Market, Global, Revenues ($m), 2002 ? 2009 25 Figure 6: Deep Brain Stimulation Devices Market, Global, Revenues ($m), 2009 ? 2016 26 Figure 7: Spinal Cord Stimulation Devices Market, Global, Revenues ($m), 2002 ? 2009 27 Figure 8: Spinal Cord Stimulation Devices Market, Global, Revenues ($m), 2009 ? 2016 28 Figure 9: Vagus Nerve Stimulation Devices Market, Global, Revenues ($m), 2002 ? 2009 29 Figure 10: Vagus Nerve Stimulation Devices Market, Global, Revenues ($m), 20016 30 Figure 11: Neurostimulation Devices Market, Global, Market Analysis by Countries, 2002 ? 2016 31 Figure 12: Neurostimulation Devices Market, US, Revenues ($m), By Segment, 2002 – 2009 32 Figure 13: Neurostimulation Devices Market, US, Revenues ($m), By Segment, 2009 – 2016 33 Figure 14: Neurostimulation Devices Market, Canada, Revenues ($m), By Segment, 2002 – 2009 34 Figure 15: Neurostimulation Devices Market, Canada, Revenues ($m), By Segment, 2009 – 2016 35 Figure 16: Neurostimulation Devices Market, UK Revenues ($m), By Segment, 2002 – 2009 36 Figure 17: Neurostimulation Devices Market, UK, Revenues ($m), By Segment, 2009 – 2016 37 Figure 18: Neurostimulation Devices Market, Germany, Revenues ($m), By Segment, 2002 – 2009 38 Figure 19: Neurostimulation Devices Market, Germany, Revenues ($m), By Segment, 2009 – 2016 39 Figure 20: Neurostimulation Devices Market, France, Revenues ($m), By Segment, 2002 – 2009 40 Figure 21: Neurostimulation Devices Market, France, Revenues ($m), By Segment, 2009 – 2016 41 Figure 22 Neurostimulation Devices Market, Italy, Revenues ($m), By Segment, 2002 – 2009 42 Figure 23: Neurostimulation Devices Market, Italy, Revenues ($m), By Segment, 2009 – 2016 43 Figure 24: Neurostimulation Devices Market, Spain, Revenues ($m), By Segment, 2002 – 2009 44 Figure 25: Neurostimulation Devices Market, Spain, Revenues ($m), By Segment, 2009 – 2016 45 Figure 26: Neurostimulation Devices Market, Japan, Revenues ($m), By Segment, 2002 – 2009 46 Figure 27: Neurostimulation Devices Market, Japan, Revenues ($m), By Segment, 2009 – 2016 47 Figure 28: Neurostimulation Devices Market, China, Revenues ($m), By Segment, 2002 – 2009 48 Figure 29: Neurostimulation Devices Market, China, Revenues ($m), By Segment, 2009 – 2016 49 Figure 30: Neurostimulation Devices Market, India, Revenues ($m), By Segment, 2002 – 2009 50 Figure 31: Neurostimulation Devices Market, India, Revenues ($m), By Segment, 2009 – 2016 51 Figure 32: Neurostimulation Devices Market, Australia, Revenues ($m), By Segment, 2002 ? 2009 52 Figure 33: Neurostimulation Devices Market, Australia. Revenues ($m), By Segment, 2009 – 2016 53 Figure 34: Neurostimulation Devices Market, Brazil, Revenues ($m), By Segment, 2002 ? 2016 54 Figure 35: Neurostimulation Devices Market, Brazil, Revenues ($m), By Segment, 2009 – 2016 55 Figure 36: : Neurostimulation Devices Market, Global, Key Company Shares (%), 2009 56 Figure 37: Pipeline Product Assessment for Neurostimulation Devices by Segment, Global 64 Figure 38: Neurostimulation Devices Market, Global, Deals Overview, 2005 ? 2009 67 Figure 39: Neurostimulation Devices Market, Global, M&A Deal Value ($m), 2005 ? 2009 68 Figure 40: GlobalData Methodology 74 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||


